Forbes Thomas L, Harding Gregory E J, Lawlor D Kirk, Derose Guy, Harris Kenneth A
Division of Vascular Surgery, London Health Sciences Centre and The University of Western Ontario, London, ON, Canada.
J Vasc Surg. 2006 Nov;44(5):938-42. doi: 10.1016/j.jvs.2006.07.038.
Transrenal fixation of abdominal aortic endografts may provide a more secure proximal attachment with few deleterious effects with respect to renal function. This study's purpose was to determine whether different metals used in two commercially available endografts (Cook Zenith and Medtronic Talent) result in different effects on renal function when placed across renal ostia.
A total of 140 consecutive patients, between August 2003 and April 2005, who underwent elective endovascular repair of an aortic aneurysm with a nitinol or stainless steel-based endograft with transrenal fixation were reviewed with a mean follow-up period of 5.5 months (range, 1-22 months). The main outcome variable was the percentage change in creatinine clearance (CrCl), which was determined before surgery and at the most recent follow-up. Multiple regression analysis was performed to analyze the contribution of various factors to any deterioration in renal function.
The 140 patients were predominantly male (86%), with a mean age of 75 years (range, 56-92) and a mean aneurysm diameter of 62 mm (range, 42-110 mm). The mean intraoperative contrast use was 67 mL (range, 45-160 mL), and after surgery these patients received a mean of 3 surveillance computed tomographic scans (range, 1-7). Nineteen cases (13.6%) required deliberate accessory renal artery coverage. CrCl did not change significantly after surgery; the mean change in CrCl at the end of follow-up was a 2.5% decrease. There was no difference in the reduction in CrCl between endograft types. Only 14.3% of patients experienced a greater than 20% decrease in CrCl. Multiple regression analysis failed to show a relationship between change in renal function and age, sex, aneurysm diameter, infrarenal neck dimensions, endograft type, coverage of accessory renal arteries, intraoperative contrast volume, preoperative CrCl, and postoperative computed tomographic scans. Length of follow-up was an independent predictor (P = .04).
Transrenal endograft fixation results in little deterioration in renal function during intermediate follow-up. The few patients who do experience a decline in renal function do so independently of any features related to the initial endovascular repair, and there is no difference in renal deterioration between endografts with nitinol and stainless steel transrenal bare metal stents.
经肾固定腹主动脉腔内移植物可能提供更可靠的近端附着,且对肾功能的有害影响较小。本研究的目的是确定两种市售腔内移植物(库克Zenith和美敦力Talent)中使用的不同金属在横跨肾动脉开口放置时是否会对肾功能产生不同影响。
回顾了2003年8月至2005年4月期间连续140例行择期血管腔内修复主动脉瘤的患者,这些患者使用了基于镍钛合金或不锈钢的带经肾固定的腔内移植物,平均随访期为5.5个月(范围1 - 22个月)。主要结局变量是肌酐清除率(CrCl)的变化百分比,在手术前和最近一次随访时测定。进行多元回归分析以分析各种因素对肾功能恶化的影响。
140例患者以男性为主(86%),平均年龄75岁(范围56 - 92岁),动脉瘤平均直径62 mm(范围42 - 110 mm)。术中平均造影剂用量为67 mL(范围45 - 160 mL),术后这些患者平均接受3次监测计算机断层扫描(范围1 - 7次)。19例(13.6%)需要特意覆盖肾副动脉。术后CrCl无显著变化;随访结束时CrCl的平均变化为下降了2.5%。不同类型腔内移植物之间CrCl的降低无差异。只有14.3%的患者CrCl下降超过20%。多元回归分析未显示肾功能变化与年龄、性别、动脉瘤直径、肾下颈部尺寸、腔内移植物类型、肾副动脉覆盖情况、术中造影剂用量、术前CrCl以及术后计算机断层扫描之间存在关联。随访时间是一个独立的预测因素(P = 0.04)。
经肾腔内移植物固定在中期随访期间导致肾功能几乎没有恶化。少数确实出现肾功能下降的患者,其肾功能下降与初始血管腔内修复的任何特征无关,并且使用镍钛合金和不锈钢经肾裸金属支架的腔内移植物在肾功能恶化方面没有差异。